S. Singh

发表

Class III drugs and congestive heart failure: focus on the congestive heart failure-survival trial of antiarrhythmic therapy.

R. Fletcher, S. Singh, 1999, The American journal of cardiology.

Congestive heart failure: survival trial of antiarrhythmic therapy (CHF STAT). The CHF STAT Investigators.

P. Deedwania, S. Fisher, R. Fletcher, 1992, Controlled Clinical Trials.

Veterans Affairs congestive heart failure antiarrhythmic trial. CHF STAT Investigators.

P. Deedwania, S. Fisher, B. Singh, 1993, The American journal of cardiology.

Effects of amiodarone on tumor necrosis factor-alpha levels in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

F. Morady, H. Oral, S. Fisher, 1999, The American journal of cardiology.

Effects of Acebutolol on Chronic Stable Angina Pectoris: A Placebo‐controlled, Double‐blind, Randomized Crossover Study

J. Gottdiener, D. Spodick, R. Dibianco, 1980, Circulation.

Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. CHF-STAT Investigators.

M. Radford, B. Massie, P. Deedwania, 1996, Circulation.

Electrophysiologic and clinical effects of angiotensin-converting enzyme inhibitors in patients with prior myocardial infarction, nonsustained ventricular tachycardia, and depressed left ventricular function. MUSTT Investigators. Multicenter UnSustained Tachycardia Trial.

K. Lee, D. Wyse, A. Buxton, 2001, The American journal of cardiology.

Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy. Department of Veterans Affairs CHF STAT Investigators.

S. Fisher, P. Carson, R. Fletcher, 1998, Journal of the American College of Cardiology.

Pulmonary effect of amiodarone in patients with heart failure. The Congestive Heart Failure-Survival Trial of Antiarrhythmic Therapy (CHF-STAT) Investigators (Veterans Affairs Cooperative Study No. 320).

P. Deedwania, S. Fisher, Bramahn . Singh, 1997, Journal of the American College of Cardiology.

Prognostic value of cardiac troponin I re-elevation following percutaneous coronary intervention in high-risk patients with acute coronary syndromes.

K. Kent, A. Pichard, L. Satler, 2001, The American journal of cardiology.

Long-term effect of mexiletine on left ventricular function and relation to suppression of ventricular arrhythmia.

B. Eisenberg, E. Hughes, S. Singh, 1990, The American journal of cardiology.

Nonsustained ventricular tachycardia in severe heart failure.

S. Fisher, P. Carson, S. Singh, 1997, Circulation.

Safety and efficacy of monotherapy with fantofarone, a novel calcium channel antagonist, in patients with chronic stable angina pectoris. Fantofarone Study Group.

S. Glasser, D. Humen, S. Singh, 1997, Journal of clinical pharmacology.

Intracoronary thrombus in nontransmural myocardial infarction and in unstable angina pectoris.

N. Wolf, S. Meister, S. M. Laporte, 1983, The American journal of cardiology.

Hemodynamic effects of the class III antiarrhythmic drug, d-sotalol, in patients with congestive heart failure.

S. Gottlieb, J. Hanyok, M. Munger, 1996, The American journal of cardiology.

Long‐term double‐blind evaluation of amlodipine and nadolol in patients with stable exertional angina pectoris

Steven N. Singh, S. Singh, 1993, Clinical cardiology.

Comparison of acebutolol and propranolol for treatment of chronic ventricular arrhythmia: a placebo-controlled, double-blind, randomized crossover study.

J. Gottdiener, R. Dibianco, Steven N. Singh, 1982, Circulation.

Effect of acebutolol on left ventricular performance.

R. Dibianco, R. Fletcher, R. Costello, 1985, American heart journal.

Role of aminophylline in refractory heart failure: a comparison to the vasodilator sodium nitroprusside, the old and the new

R. Dibianco, R. Fletcher, R. Katz, 1980, Clinical cardiology.

Contrast echocardiographic documentation of paradoxical embolism.

S. Meister, S. Singh, D. Rodgers, 1984, American heart journal.

Relation between ventricular function and antiarrhythmic responses to sotalol.

R. Woosley, R. Fletcher, A. Cohen, 1989, The American journal of cardiology.

Sotalol for refractory sustained ventricular tachycardia and nonfatal cardiac arrest.

J. Gottdiener, R. Fletcher, M. Wish, 1988, The American journal of cardiology.

Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators.

R. Falk, Steven N. Singh, R H Falk, 1997, Journal of the American College of Cardiology.

A review of the effects of disopyramide phosphate on left ventricular function and the peripheral circulation.

J. Gottdiener, R. Fletcher, S. Singh, 1987, Angiology.

Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators.

P C Deedwania, K. Ellenbogen, P. Deedwania, 1998, Circulation.

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.

P C Deedwania, R D Fletcher, B. Massie, 1995, The New England journal of medicine.

Sotalol-induced torsades de pointes successfully treated with hemodialysis after failure of conventional therapy.

R. Fletcher, M. Johnson, A. Cohen, 1991, American heart journal.

Amlodipine versus nadolol in patients with stable angina pectoris.

J. Gorwit, S. Singh, S. Bekheit, 1989, American heart journal.

Efficacy and safety of sotalol in digitalized patients with chronic atrial fibrillation. The Sotalol Study Group.

J. Kluger, R. Gold, S. Singh, 1991, American Journal of Cardiology.

Lorcainide for high-frequency ventricular arrhythmia: preliminary results of a short-term double-blind and placebo-controlled crossover study and long-term follow-up.

R. Dibianco, R. Fletcher, S. Singh, 1984, The American journal of cardiology.

Efficacy and tolerance of Ethmozine (moricizine HCl) in placebo-controlled trials.

H. Kennedy, D. Mason, C. Pratt, 1987, The American journal of cardiology.

Usefulness of d, I sotalol for suppression of chronic ventricular arrhythmias.

S. Saksena, J. Anderson, R. Freedman, 1991, The American journal of cardiology.

Antiarrhythmic drug therapy in the Multicenter UnSustained Tachycardia Trial (MUSTT): drug testing and as-treated analysis.

W. Kou, D. Wyse, D. Packer, 2001, Journal of the American College of Cardiology.

Effect of moricizine hydrochloride in reducing chronic high-frequency ventricular arrhythmia: results of a prospective, controlled trial.

J. Gottdiener, R. Dibianco, S. Singh, 1984, The American journal of cardiology.

Prediction of electrophysiologic study results in patients treated with amiodarone.

J. Fisher, K. Ferrick, S. Kim, 1995, American heart journal.